146 related articles for article (PubMed ID: 33197301)
21. Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers.
Fehl DJ; Ahmed M
Virus Res; 2017 Jan; 228():14-23. PubMed ID: 27865863
[TBL] [Abstract][Full Text] [Related]
22. Screening interferon antagonists from accessory proteins encoded by P gene for immune escape of Caprine parainfluenza virus 3.
Sun M; Li W; Zhang W; Yang L; Hao F; Li J; Mao L; Jiang J; Liu M
Vet Microbiol; 2021 Mar; 254():108980. PubMed ID: 33445054
[TBL] [Abstract][Full Text] [Related]
23. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
[TBL] [Abstract][Full Text] [Related]
24. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
[No Abstract] [Full Text] [Related]
25. Rotavirus Reprograms Multiple Interferon Receptors and Restricts Their Intestinal Antiviral and Inflammatory Functions.
Sen A; Namsa ND; Feng N; Greenberg HB
J Virol; 2020 Feb; 94(6):. PubMed ID: 31896593
[TBL] [Abstract][Full Text] [Related]
26. Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy.
Liu YP; Suksanpaisan L; Steele MB; Russell SJ; Peng KW
Sci Rep; 2013; 3():2375. PubMed ID: 23921465
[TBL] [Abstract][Full Text] [Related]
27. Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses.
Hwang M; Bergmann CC
J Virol; 2018 May; 92(10):. PubMed ID: 29491163
[TBL] [Abstract][Full Text] [Related]
28. IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN-stimulated genes.
Xu L; Zhou X; Wang W; Wang Y; Yin Y; Laan LJ; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
FASEB J; 2016 Oct; 30(10):3352-3367. PubMed ID: 27328944
[TBL] [Abstract][Full Text] [Related]
29. Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus.
Aref S; Castleton AZ; Bailey K; Burt R; Dey A; Leongamornlert D; Mitchell RJ; Okasha D; Fielding AK
Mol Ther; 2020 Apr; 28(4):1043-1055. PubMed ID: 32087150
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic Ras inhibits IRF1 to promote viral oncolysis.
Komatsu Y; Christian SL; Ho N; Pongnopparat T; Licursi M; Hirasawa K
Oncogene; 2015 Jul; 34(30):3985-93. PubMed ID: 25347735
[TBL] [Abstract][Full Text] [Related]
31. Fish virus-induced interferon exerts antiviral function through Stat1 pathway.
Yu FF; Zhang YB; Liu TK; Liu Y; Sun F; Jiang J; Gui JF
Mol Immunol; 2010 Aug; 47(14):2330-41. PubMed ID: 20627394
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
33. Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants.
Muster T; Rajtarova J; Sachet M; Unger H; Fleischhacker R; Romirer I; Grassauer A; Url A; García-Sastre A; Wolff K; Pehamberger H; Bergmann M
Int J Cancer; 2004 May; 110(1):15-21. PubMed ID: 15054864
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be susceptible to oncolytic vesicular stomatitis virus through down-regulation of HDAC4.
Moon J; Kaowinn S; Cho IR; Min DS; Myung H; Oh S; Kaewpiboon C; Kraemer OH; Chung YH
Biochem Biophys Res Commun; 2016 Jun; 474(3):428-434. PubMed ID: 27150631
[TBL] [Abstract][Full Text] [Related]
35. Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.
Hu C; Liu Y; Lin Y; Liang JK; Zhong WW; Li K; Huang WT; Wang DJ; Yan GM; Zhu WB; Qiu JG; Gao X
Cell Death Dis; 2018 Feb; 9(3):274. PubMed ID: 29449555
[TBL] [Abstract][Full Text] [Related]
36.
Li G; Cheng J; Mei S; Wu T; Ye T
Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29880736
[TBL] [Abstract][Full Text] [Related]
37. Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.
Edukulla R; Woller N; Mundt B; Knocke S; Gürlevik E; Saborowski M; Malek N; Manns MP; Wirth T; Kühnel F; Kubicka S
Cancer Res; 2009 Feb; 69(4):1448-58. PubMed ID: 19190348
[TBL] [Abstract][Full Text] [Related]
38. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
[TBL] [Abstract][Full Text] [Related]
39. Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells.
Osali A; Zhiani M; Ghaebi M; Meymanat M; Esmaeilzadeh A
Pharmacol Res; 2020 Nov; 161():105094. PubMed ID: 32795509
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
